The DOI matches its OpenAlex record; 29 of the 29 references it cites were found in a registry or an index.
The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta
Open accessAbstract
Cyclical pamidronate infusions increase bone mass in children suffering from osteogenesis imperfecta. The histological basis for these effects remains unknown. Therefore, we compared parameters of iliac bone histomorphometry from 45 patients before and after 2.4 +/- 0.6 years of pamidronate treatment (age at the time of the first biopsy, 1.4-17.5 years; 23 girls). Although biopsy size did not change significantly (P = 0.30), cortical width increased by 88%. Cancellous bone volume increased by 46%. This was due to a higher trabecular number, whereas trabecular thickness remained stable. Bone surface-based indicators of cancellous bone remodeling decreased by 26-75%. There was no evidence for a mineralization defect in any of the patients. These results suggest that, in the growing skeleton, pamidronate has a twofold effect. In remodeling, bone resorption and formation are coupled and consequently both processes are inhibited. However, osteoclasts and osteoblasts are active on different surfaces (and are thus uncoupled) during modeling of cortical bone. Therefore resorption is selectively targeted, and continuing bone formation can increase cortical width.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Self-citationBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Self-citationPhysical growth: National Center for Health Statistics percentiles
Hamill, P. V. V., Drizd, T., Johnson, C., Reed, R., Roche, A., & Moore, W. (1979) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.3.607 · Cited by 2,323
Genetic heterogeneity in osteogenesis imperfecta.
Sillence, D. O., Senn, A., & Danks, D. M. (1979) · Journal of Medical Genetics · doi:10.1136/jmg.16.2.101 · Cited by 2,229
New approaches for interpreting projected bone densitometry data
Professor Carter, D. R., Bouxsein, M. L., & Marcus, R. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070204 · Cited by 1,065
Bisphosphonates: Mechanisms of Action
Fleisch, H. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,019
Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta
Glorieux, F. H., Bishop, N. J., Plotkin, H., Chabot, G., Lanoue, G., & Travers, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391402 · Cited by 1,015
Self-citationAlendronate for the Treatment of Osteoporosis in Men
Orwoll, E., Ettinger, M., Weiss, S., Miller, P., Kendler, D., Graham, J., Adami, S., Weber, K., Lorenc, R., Pietschmann, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430902 · Cited by 973
Frost, H. M. (1990) · The Anatomical Record · doi:10.1002/ar.1092260402 · Cited by 956
Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density
Reid, I. R., Brown, J. P., Burckhardt, P., Horowitz, Z., Richardson, P., Trechsel, U., Widmer, A., Devogelaer, J.-P., Kaufman, J.-M., Jaeger, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011807 · Cited by 877
Bone Microdamage and Skeletal Fragility in Osteoporotic and Stress Fractures
Burr, D. B., Forwood, M. R., Fyhrie, D. P., Martin, R. B., Schaffler, M. B., & Turner, C. H. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.6 · Cited by 686
Ganguly, A., Rock, M. J., & Prockop, D. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10325 · Cited by 674
Boivin, G. Y., Chavassieux, P. M., Santora, A. C., Yates, J., & Meunier, P. J. (2000) · Bone · doi:10.1016/s8756-3282(00)00376-8 · Cited by 574
Chavassieux, P. M., Arlot, M. E., Reda, C., Wei, L., Yates, A. J., & Meunier, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119668 · Cited by 523
Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease
Glorieux, F. H., Rauch, F., Plotkin, H., Ward, L., Travers, R., Roughley, P., Lalic, L., Glorieux, D. F., Fassier, F., & Bishop, N. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.9.1650 · Cited by 516
Self-citationOsteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization Defect
Glorieux, F. H., Ward, L. M., Rauch, F., Lalic, L., Roughley, P. J., & Travers, R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.30 · Cited by 446
Self-citationTargeted and nontargeted remodeling
Burr, D. B. (2002) · Bone · doi:10.1016/s8756-3282(01)00619-6 · Cited by 414
Normative data for iliac bone histomorphometry in growing children
Glorieux, F. H., Travers, R., Taylor, A., Bowen, J. R., Rauch, F., Norman, M., & Parfitt, A. M. (2000) · Bone · doi:10.1016/s8756-3282(99)00257-4 · Cited by 337
Self-citationStatic and dynamic bone histomorphometry in children with osteogenesis imperfecta
Rauch, F., Travers, R., Parfitt, A. M., & Glorieux, F. H. (2000) · Bone · doi:10.1016/s8756-3282(00)00269-6 · Cited by 328
Self-citationPamidronate Treatment of Severe Osteogenesis Imperfecta in Children under 3 Years of Age
Plotkin, H. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1846 · Cited by 315
Self-citationStructural and cellular changes during bone growth in healthy children
Parfitt, A. M., Travers, R., Rauch, F., & Glorieux, F. H. (2000) · Bone · doi:10.1016/s8756-3282(00)00353-7 · Cited by 286
Self-citationMetabolic Bone Disease and Clinically Related Disorders
(1998) · Elsevier eBooks · doi:10.1016/b978-0-12-068700-8.x5000-2 · Cited by 276
Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease
Ward, L. M., Rauch, F., Travers, R., Chabot, G., Azouz, E. M., Lalic, L., Roughley, P. J., & Glorieux, F. H. (2002) · Bone · doi:10.1016/s8756-3282(02)00790-1 · Cited by 270
Self-citationBeneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
Astrom, E. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.5.356 · Cited by 259
Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.
Halasy-Nagy, J. M., Rodan, G. A., & Reszka, A. A. (2001) · Bone · doi:10.1016/s8756-3282(01)00615-9 · Cited by 190
Körkkö, J., Ala-Kokko, L., De Paepe, A., Nuytinck, L., Earley, J., & Prockop, D. J. (1998) · The American Journal of Human Genetics · doi:10.1086/301689 · Cited by 179
Pataki, A., Müller, K., Green, J. R., Ma, Y. F., Li, Q. N., & Jee, W. S. S. (1997) · The Anatomical Record · Cited by 113
Chavassieux, P., ARLOT, M. E., Roux, J. P., Portero-Muzy, N., Daifotis, A. G., Yates, A. J. P., Hamdy, N. A. T., Malice, M., Freedholm, D., & Meunier, P. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.754 · Cited by 104
Bone Histomorphometric Evaluation of Pamidronate Treatment in Clinically Manifest Osteoporosis
Bravenboer, N., Papapoulos, S. E., Holzmann, P. J., Hamdy, N. A. T., Netelenbos, J. C., & Lips, P. T. A. M. (1999) · Osteoporosis International · doi:10.1007/s001980050175 · Cited by 44
Cited by
Bisphosphonates: Mechanism of action and role in clinical practice
Drake, M. T., Clarke, B. L., & Khosla, S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.9.1032 · Cited by 1,644
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chan, A. K. C., Goldenberg, N. A., Ichord, R. N., Journeycake, J. M., Nowak-Göttl, U., & Vesely, S. K. (2012) · Chest · doi:10.1378/chest.11-2308 · Cited by 1,491
Forlino, A., & Marini, J. C. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00728-x · Cited by 942
Marini, J. C., Forlino, A., Bächinger, H. P., Bishop, N. J., Byers, P. H., Paepe, A. D., Fassier, F., Fratzl-Zelman, N., Kozloff, K. M., Krakow, D., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.52 · Cited by 842
New perspectives on osteogenesis imperfecta
Forlino, A., Cabral, W. A., Barnes, A. M., & Marini, J. C. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.81 · Cited by 727
Metadata
- Authors
- Rauch, F., Travers, R., Plotkin, H., & Glorieux, F. H.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2002-11-01
- Volume
- 110
- Issue
- 9
- Pages
- 1293-1299
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2080643168
- Cited by
- 291
- References
- 29
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.